Identification and characterization of protozoan products that trigger the synthesis of IL-12 by inflammatory macrophages

Chemical Immunology

Volumn 68, Issue , 1997, Pages 136-152

  Gazzinelli, Ricardo T ^a,b,d   Camargo, Maristela M ^a,b   Almeida, Igor C ^f   Morita, Yasu S ^e   Giraldo, Mónica ^a,b   Acosta Serrano, Alvaro ^e   Hieny, Sara ^d   Englund, Paul T ^e   Ferguson, Michael A J ^f   Travassos, Luiz R ^c   Sher, Alan ^d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GLYCOLIPID; GLYPICAN; INTERLEUKIN 12;

ANIMAL CELL; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MOUSE; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTOZOON; REVIEW; TRYPOMASTIGOTE;

EID: 0030921707     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058689     Document Type: Review

References (67)

1. Trinchieri G: Interleukin-12: A pro-inflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptative immunity. Annu Rev Immunol 1995;13:252-276.
2. Biron CA, Gazzinelli RT: IL-12 effects on immune responses to microbial infections: A key mediator in regulating disease outcome. Curr Opin Immunol 1995;7:485-496.
3. Gazzinelli RT, Hieny S, Wynn T, Wolf S, Sher A: IL-12 is required for the T-cell independent induction of IFN-γ by an intracellular parasite and induces resistance in T-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-6119.
4. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A: Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994;153:2533-2543.
5. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A: In absence of endogenous IL-10 mice acutely infected with Toxoplasmic gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ, TNF-α. J Immunol 1996;157:798-805.
6. Aliberti JCS, Cardoso MAG, Martins GA, Gazzinelli RT, Vieira LQ, Silva JS: IL-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 1996;64:1961-1967.
7. Khan IA, Matsuura T, Kasper LH: Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 1994;62:1639-1642.
8. Hunter CA, Subauste CS, van Cleave VH, Remington J: Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID:mice regulation by interleukin-10, interleukin-12 and tumor necrosis factor-alpha. Infect Immun 1994;62:2818-2824.
9. Hunter CA, Candolfi CA, Subauste C, van Cleave VH, Remington J: Studies on the role of IL-12 in murine toxoplasmosis. Immunology 1995;84:16-20.
10. Hunter CA, Slifer T, Araujo F: Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor-alpha and gamma interferon. Infect Immun 1996;64:2381-2386.
11. Hunter CA, Chizzonite R, Remington J: IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. J Immunol 1995;155:4347-4354.
12. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri M: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 1995;96:2578-2582.
13. Gazzinelli RT, Amichay D, Scharton-Kersten T, Grunvald E, Farber JM, Sher A: Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. Curr Top Microb Immunol 1996;219:127-140.
14. Gazzinelli RT: Molecular and cellular basis of interleukin-12 activity in prophylaxis and therapy against infectious diseases. Mol Med Today 1996;2:258-267.
15. Hauser WE Jr, Sharma SD, Remington J: Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii. J Immunol 1983;131:458-463.
16. Hatcher FM, Kuhn RE: Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi. J Immunol 1981;126: 2436-2442.
17. Hatcher FM, Kuhn RE, Cerrone MC, Burton RC: Increased natural killer cell activity in experimental American trypanosomiasis. J Immunol 1981;1127:1126-1130.
18. Ruskins J, Remington J: Immunity and intracellular infection: Resistance to bacteria in mice infected with a protozoan. Science 1968;160:72-74.
19. Mahmoud AAF, Warren KS, Strickland GT: Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature 1976;263:56-57.
20. Ortiz-Ortiz L, Ortega T, Capin R, Martinez T: Enhanced mononuclear phagocytic activity during Trypanosoma cruzi infection in mice. Int Arch Allergy Appl Immunol 1976;50:232-242.
21. Kierszenbaum F, Sonnenfeld G: Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease. J Parasitol 1982;68:194-198.
22. Hibbs JB, Lambert LH, Remington J: Resistance to murine tumours conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis 1971;124:587-592.
23. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-54.
24. Hsieh CS, Macatonia SE, Tripp CS, Wolf S, O'Garra A, Murphy KM: Development of ThI CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
25. Seder RA, Gazzinelli RT, Sher A, Paul WE: IL-12 acts directly on CD4+ T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-10192.
26. Tripp CS, Kanagawa O, Unanue E: Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12. J Immunol 1995;155:3427-3432.
27. Reiner SL, Zheng SC, Wang ZE, Stowring L, Locksley RM: Leishmania promastigotes evade interleukin-12 induction by macrophages and stimulate a broad range of cytokines from CD4(+) T cells during initiation of infection. J Exp Med 1994;179:447-456.
28. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL: Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996;183:515-526.
29. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmman T, Belosevic M: Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-γ responses and increased production of helper 2 cytokines. J Immunol 1996;156:644-652.
30. Oliveira MAP, Santiago HC, Lisboa CR, Ceravolo IP, Gazzinelli RT, Vieira LQ: Different species of Leishmania induce IL-12 and IFN-γ production by murine cells distinctively from Trypanosoma cruzi and Toxoplasma gondii. Mem Inst Oswaldo Cruz 1996;91(suppl):168.
31. Grunvald E, Chiaramonte M, Hieny S, Wysocka M, Trinchieri G, Vogel SN, Gazzinelli RT, Sher A: Biochemical characterization and protein kinase C dependency of monokine inducing activities in Toxoplasma gondii. Infect Immun 1996;64:2010-2018.
32. Camargo MM, Almeida IC, Pereira MES, Ferguson MAJ, Travassos LR, Gazzinelli RT: GPI-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of pro-inflammatory cytokines by macrophages. J Immunol 1997;158:5890-5901.
33. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G: The interleukin-12 p40 promoter is primed by interferon-γ in monocytic cells. J Exp Med 1996;183:147-157.
34. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A: In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 1996;157:4045-4054.
35. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med 1993;177:1505-1509.
36. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177:1797-1802.
37. Afonso LCC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P: The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-237.
38. Silva JS, Vespa GNR, Cardoso MAG, Aliberti JCS, Cunha FQ: Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995;63:4862-4867.
39. Van Voorhis WC: Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J Immunol 1992;148:239-248.
40. Sher A, Oswald IP, Hieny S, Gazzinelli RT: Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J Immunol 1993;150:3982-3989.
41. McConville MJ, Blackwell JM: Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. J Biol Chem 1991;266:15170-15179.
42. Almeida IC, Ferguson MAJ, Schenkman S, Travassos LR: Lytic anti-α-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J 1994;304: 793-802.
43. Serrano AA, Schenkman S, Yoshida N, Mehlert A, Richardson JM, Ferguson MAJ: The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. J Biol Chem 1995;270:27244-27253.
44. Schenkman S, Ferguson MAJ, Heise N, Almeida MLC, Mortara R, Yoshida N: Mucin-like glycoproteins linked to the membrane by GPI anchor are the major acceptor of sialic acid in a reaction catalyzed by trans-sialidase in metacyclic forms of Trypanosoma cruzi. Mol Biochem Parasitol 1993; 59:293-303.
45. Reiner NE, Ng W, Wilson CB, McMaster WR, Burchett S: Modulation of in vitro monocyte responses to Leishmania donovani. J Clin Invest 1990;85:1914-1924.
46. Descoteaux A, Matlashewski G, Turco SJ: Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 1992;149:3008-3015.
47. Descoteaux A, Turco SJ, Sacks DL, Matlashewski G: Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol 1991;146:2747-2753.
48. Frankenburg S, Leibovici V, Mansbach N, Turco SJ, Rosen G: Effects of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. J Immunol 1990;145: 4284-4289.
49. Moore KJ, Labrecque S, Matlashewski G: Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. J Immunol 1993;150:4457-4465.
50. Moore KJ, Matlashewski G: Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 1994;152:2930-2937.
51. Proudfoot L, O'Donnell CA, Liew FY: Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol 1995;25:745-750.
52. McConville MJ, Turco SJ, Ferguson MAJ, Sacks DL: Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J 1992;11:3593-3600.
53. Orlandi PA, Turco SJ: Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J Biol Chem 1987;262:10384-10391.
54. Kramer IM, van der Bend RL, Tool AT, van Blitterswijk WJ, Roos D, Verhoeven AJ: 17-O-hexadecyl-2-Q-methylglycerol, a novel inhibitor of protein kinase C, inhibits respiratory burst in human neutrophils. J Biol Chem 1989;264:5876-5884.
55. Schofield L, Hackett F: Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med 1993;177:145-153.
56. Schofield L, Novakovic P, Gerold P, Schwarz RT, McConville MJ, Tachado SD: Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin expression in vascular endothelium cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 1996; 156:1886-1896.
57. Tachado SD, Gerold P, McConville MJ, Baldwin T, Quilici B, Schwarz RT, Schofield L: Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelium cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol 1996;156:1897-1907.
58. Tachado SD, Schofield L: Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1α and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem Biophys Res Commun 1995;205:984-991.
59. Bate CAW, Kwiatkowski D: A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum. Infect Immun 1994;62:5261-5266.
60. Gerold P, Dieckmann-Schuppert A, Schwarz RT: Glycosylphosphatidylinositol synthesized by a sexual erythrocytic stages of the malarial parasite, Plasmodium falciparum. Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenic factors. J Biol Chem 1994;269:2597-2606.
61. Gerold P, Schofield L, Blackman MJ, Holder AA, Schwarz RT: Structural analysis of the glycosylphosphatidylinositol membrane anchor of the merozoite surface proteins-1 and -2 of Plasmodium falciparum. Mol Biochem Parasitol 1996;75:131-143.
62. Ferguson MAJ, Howans SW, Dwek RA, Rademacher TW: Glycosyl-phosphatidylinositol moiety that anchors Trypanosomabrucei variant surface glycoprotein to the membrane. Science 1988;239:753-759.
63. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM: Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD-14-dependent pathway. Infect Immun 1996;64:1906-1912.
64. Krieg AM: An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J Lab Clin Med 1996;128:128-133.
65. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs in bacteria DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12 and interferon-gamma. Proc Natl Acad Sci USA 1996;93:2879-2883.
66. Skeiky YAW, Guderian JA, Benson DR, Bacelar O, Carvalho E, Kubin M, Badaro R, Trinchieri G, Reed SG: A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce IL-12. J Exp Med 1995;181: 1527-1537.
67. Beverley SM: Hijacking the cell: Parasites in the driver's seat. Cell 1996;87:787-789.